Urodinamska dijagnoza subvezikalne opstrukcije – značaj indeksa opstrukcije vrata mokraćne bešike i indeksa kontraktilnosti mokraćne bešike
Sažetak
Uvod/Cilj. Indeks opstrukcije vrata mokraćne bešike [bladder outlet obstruction (BOO) index – BOOI] koristi se prilikom urodinamskog ispitivanja sa ciljem postavljanja dijagnoze BOO. Indeks kontraktilnosti mokraćne bešike (bladder contractility index – BCI) je urodinamski parametar koji se nekonzistentno koristi u praksi. Cilj rada bio je da se ispita korelacija između BOOI i BCI. Metode. Retrospektivna studija sprovedena je u periodu od 2021–2023 godine i obuhvatila je 176 bolesnika muškog pola. Korišćenjem t-testa, analize varijanse i analize korelacije, analizirani su BOOI i BCI. Rezultati. Visoke vrednosti BOOI (40–80) i slabija kontraktilnost bešike (BCI < 100), kao mogući uzročnici simptoma od strane donjeg urinarnog trakta (lower urinary tract symptoms – LUTS) koegzistiraju u 11,37% slučajeva. Visoka vrednost BCI (> 150) povezana je sa značajnim brojem bolesnika (7,39%) sa visokim vrednostima BOOI (> 40), delujući kao kompenzatorni mehanizam koji prikriva prave uzroke LUTS. U grupama bolesnika sa BCI < 100 i > 150 pokazana je obrnuta korelacija sa BOOI, kao što je i očekivano. Vrednosti BOOI 20–39 i BCI 101–149 mogu se smatrati „sivom zonom“. Korelacija PdetQmax i Qmax nije pokazala statističku značajnost (r = -0,2006), što čini BOO faktorom koji može uticati na ovaj odnos. Pored ovoga, intrauretralni kateter postavljen tokom urodinamskog ispitivanja može u znatnoj meri da utiče na ovaj odnos. Kao što je očekivano, uočava se negativna korelacija između Qmax i BOOI (r = -0,44841, p < 0,001), dok BCI i Qmax imaju pozitivnu linearnu korelaciju (R2 = 0,2255, p < 0,001). Korelacija između dva ispitivana indeksa, BOOI i BCI, pokazuje pozitivnu linearnu povezanost, što ukazuje na postojanje fiziološkog mehanizma za kompenzaciju BOO (R² = 0,3292, p < 0,001). Zaključak. U kombinaciji sa BCI, BOOI je dovoljan za postavljanje definitivne dijagnoze u posmatranim grupama bolesnika. Preporuka je da se BOOI, BCI i Qmax uvek koriste u kombinaciji. Qmax, kao mera koja se najviše analizira prilikom urofloumetrije, može biti nedovoljna za dijagnozu u jasnim kliničkim slučajevima.
Reference
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21(2): 167–78.
Lee CL, Kuo HC. Pathophysiology of benign prostate enlarge-ment and lower urinary tract symptoms: Current concepts. Tzu Chi Med J 2017; 29(2): 79–83.
Matsukawa Y, Naito Y, Ishida S, Matsuo K, Majima T, Gotoh M. Two types of detrusor underactivity in men with nonneuro-genic lower urinary tract symptoms. Neurourol Urodyn 2023; 42(1): 73–9.
Drake MJ, Lewis AL, Young GJ, Abrams P, Blair PS, Chapple C, et al. Diagnostic Assessment of Lower Urinary Tract Symp-toms in Men Considering Prostate Surgery: A Noninferiority Randomised Controlled Trial of Urodynamics in 26 Hospitals. Eur Urol 2020; 78(5): 701–10.
Abrams P. Bladder outlet obstruction index, bladder contrac-tility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 1999; 84(1): 14–5.
Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, et al. Prev-alence and Clinical Features of Detrusor Underactivity among Elderly with Lower Urinary Tract Symptoms: A Comparison between Men and Women. Korean J Urol 2012; 53(5): 342–8.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61(1): 37–49.
D’Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn 2019; 38(2): 433–77.
Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: min-imum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol 2005; 174(5): 1887–91.
Al-Hayek S, Thomas A, Abrams P. Natural history of detrusor contractility--minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor. Scand J Urol Nephrol Suppl 2004; (215): 101–8.
Jiang YH, Lee CL, Kuo HC. Urothelial dysfunction, suburothe-lial inflammation and altered sensory protein expression in men with bladder outlet obstruction and various bladder dys-functions: Correlation with urodynamics. J Urol 2016; 196(3): 831–7.
Averbeck MA, De Lima NG, Motta GA, Beltrao LF, Abboud Filho NJ, Rigotti CP, et al. Collagen content in the bladder of men with LUTS undergoing open prostatectomy: A pilot study. Neurourol Urodyn 2018; 37(3): 1088–94.
Kim M, Jeong CW, Oh SJ. Effect of preoperative urodynamic detrusor underactivity on transurethral surgery for benign prostatic hyperplasia: a systematic review and meta-analysis. J Urol 2018; 199(1): 237–44.
Wang J, Ren L, Liu X, Liu J, Ling Q. Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives. Int J Mol Sci 2023; 24(21): 15517.
Santos-Pereira M, Charrua A. Understanding underactive blad-der: A review of the contemporary literature. Porto Biomed J 2020; 5(4): e070.
Kim SJ, Kim J, Na YG, Kim KH. Irreversible Bladder Remodel-ing Induced by Fibrosis. Int Neurourol J 2021; 25(Suppl 1): S3–7.
Yang J, Song H, Zhan H, Ding M, Luan T, Chen J, et al. The in-fluence of preoperative urodynamic parameters on clinical re-sults in patients with benign prostatic hyperplasia after tran-surethral resection of the prostate. World J Urol 2023; 41(12): 3679–85.
Reynard JM, Yang Q, Donovan JL, Peters TJ, Schafer W, de la Ro-sette JJ, et al. The ICS-'BPH' Study: uroflowmetry, lower uri-nary tract symptoms and bladder outlet obstruction. Br J Urol 1998; 82(5): 619–23.
Malde S, Nambiar AK, Umbach R, Lam TB, Bach T, Bachmann A, et al. Systematic Review of the Performance of Noninva-sive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms. Eur Urol 2017; 71(3): 391–402.
Tammela TL, Schäfer W, Barrett DM, Abrams P, Hedlund H, Rollema HJ, et al. Repeated pressure‐flow studies in the evalu-ation of bladder outlet obstruction due to benign prostatic en-largement. Finasteride Urodynamics Study Group. Neurourol Urodyn 1999; 18(1): 17–24.
El Khoury J, Hermieu N, Chesnel C, Xylinas E, Teng M, Ouzaid I, et al. Primary bladder neck obstruction in men: The im-portance of urodynamic assessment and cystourethrography in measuring its severity. Neurourol Urodyn 2024; 43(4): 874–82.
Rosier PFWM, Gammie A, Valdevenito JP, Speich J, Smith P, Sin-ha S. ICS‐SUFU standard: Theory, terms, and recommenda-tions for pressure‐flow studies performance, analysis, and re-porting. Part 2: Analysis of PFS, reporting, and diagnosis. Neurourol Urodyn 2023; 42(8): 1603–27.
Van Dort W, Rosier PFWM, van Steenbergen TRF, Geurts BJ, de Kort LMO. Constrictive versus compressive bladder outflow obstruction in men: does it matter? Neurourol Urodyn 2024; 43(8): 2178–84.
Marshall SJ, Wang D, Fung YC, Blaivas J. Urodynamic findings that are most impactful for patients with neurogenic bladder and the literature that supports this. Curr Bladder Dysfunct Rep 2024; 19(2): 211–29.
Croghan SM, Skolarikos A, Jack GS, Manecksha RP, Walsh MT, O'Brien FJ, et al. Upper urinary tract pressures in endourology: a systematic review of range, variables and implications. BJU Int 2023; 131(3): 267–79.
